MBRX vs NVDA · $8.2M cap vs P/E 58, rev $96.22B
Moleculin Biotech Inc (MBRX) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
MBRX currently screens at market cap $8.2M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the MBRX and NVDA stock pages for the full models.
Not investment advice.